Skip to content
Research Article Open access CC BY 3.0

In vitro- In vivo Correlation Studies of Modified Release Tolterodine Tablet Dosage form in Rabbits

P. Srinivasa Babu, S. K. Rihana Parveen, K. B. Chandrasekar, B. R. Challa

Journal of Pharmaceutical Research International · pp. 1861–1872 · Published 1 Aug 2014

10.9734/BJPR/2014/9950

Abstract

Tolterodine is an antimuscarnic drug that is used for sympathetic treatment of urinary incontinence. Tolterodine modified release tablet, was investigated in rabbit for pharmacokinetic and in vitro–in vivocorrelation studies. Tablets were prepared and in vitro release was studied in simulated gastric fluid at 150RPMs. New Zealand albino male rabbits have been used as animal model for in vivo study. A sensitive and simple HPLC method was developed for the determination of Tolterodine content in rabbit plasma. In vitro release studies showed that release patterns followed zero order for around 24h. The in vivo–in vitro correlation coefficients obtained from point-to-point analysis were greater than 99% between concentrations at certain time points obtained from release study in simulated gastric fluid and HPLC analysis of rabbit’s plasma. From the in vitro–in vivo correlation prediction it was evident that the Tolterodine matrix assisted tablet is a good for controlled delivery of Tolterodine.

Tolterodine modified release In vitro–In vivo correlation.

References (24)

  1. 1 A comprehensive non‐clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder [DOI]
  2. 2 Biopharmaceutics and Relevant Pharmacokinetics [DOI]
  3. 3 Utility of Nanosized Microemulsion for Transdermal Delivery of Tolterodine Tartrate: Ex-Vivo Permeation and In-Vivo Pharmacokinetic Studies [DOI]
  4. 4 Application of a liquid chromatographic/tandem mass spectrometric method to a kinetic study of derivative glucosamine in healthy human urine [DOI]
  5. 5 Serum protein binding of tolterodine and its major metabolites in humans and several animal species [DOI]
  6. 6 Transdermal delivery of tolterodine by O-acylmenthol: In vitro/in vivo correlation [DOI]
  7. 7 Capillary solid-phase extraction–tandem mass spectrometry for fast quantification of free concentrations of tolterodine and two metabolites in ultrafiltered plasma samples [DOI]
  8. 8 Determination of tolterodine and its 5-hydroxymethyl metabolite in human plasma by hydrophilic interaction liquid chromatography–tandem mass spectrometry [DOI]
  9. 9 High performance liquid chromatography-electrospray ionization mass spectrometric determination of tolterodine tartrate in human plasma [DOI]
  10. 10 Studies on the preparation, characterization and pharmacological evaluation of tolterodine PLGA microspheres [DOI]
  11. 11 A New Rapid and Sensitive Stability-Indicating UPLC Assay Method for Tolterodine Tartrate: Application in Pharmaceuticals, Human plasma, and Urine Samples [DOI]
  12. 12 A validated LC–MS/MS method for the determination of tolterodine and its metabolite in rat plasma and application to pharmacokinetic study [DOI]
  13. 13 Report of the Workshop on In Vitro and In Vivo Testing and Correlation for Oral Controlled/Modified-Release Dosage Forms [DOI]
  14. 14 Column switching in capillary liquid chromatography–tandem mass spectrometry for the quantitation of pg/ml concentrations of the free basic drug tolterodine and its active 5-hydroxymethyl metabolite in microliter volumes of plasma [DOI]
  15. 15 Determination of tolterodine and the 5-hydroxymethyl metabolite in plasma, serum and urine using gas chromatography-mass spectrometry [DOI]
  16. 16 A validated chiral HPLC method for the enantiomeric separation of tolterodine tartarate [DOI]
  17. 17 Enantiomeric purity methods for three pharmaceutical compounds by electrokinetic capillary chromatography utilizing highly sulfated-γ-cyclodextrin as the chiral selector [DOI]
  18. 18 Effect of the CYP2D6*10 Genotype on Tolterodine Pharmacokinetics [DOI]
  19. 19 An enantiospecific HPLC method for the determination of (S)-enantiomer impurities in (R)-tolterodine tartarate [DOI]
  20. 20 Comparative Analysis of the Effects of Antimuscarinic Agents on Bladder Functions in Both Nonhuman Primates and Rodents [DOI]
  21. 21 Liquid chromatography–atmospheric pressure chemical ionization tandem mass spectrometry for the simultaneous determination of dimethoxyaschantin, dimethylliroresinol, dimethylpinoresinol, epimagnolin A, fargesin and magnolin in rat plasma [DOI]
  22. 22 Silicone adhesive, a better matrix for tolterodine patches—a research based onin vitro/in vivostudies [DOI]
  23. 23 Reverse-phase, high performance liquid chromatographic method for the determination of tolterodine tartrate in routine quality control samples.
  24. 24 Simultaneous determination of magnolin and epimagnolin A in rat plasma by liquid chromatography with tandem mass spectrometry: Application to pharmacokinetic study of a purified extract of the dried flower buds of Magnolia fargesii, NDC-052 in rats [DOI]

Cited by 2

Potential Use of Polyvinyl Acetate–Polyvinylpyrrolidone Mixture for the Development of Atenolol Sustained Release Matrix Tablets: Optimization of Formulation through <i>in Vitro</i>–<i>in Vivo</i> Assessment Study

Ali Saeed Owayez, Galal Mahmoud Abd El-ghany, Irhan Ibrahim Abu Hashim · CHEMICAL & PHARMACEUTICAL BULLETIN · 2017

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Related research

Article metrics

Real usage data collected on this platform.

16

Page views

0

PDF downloads

6

Outbound clicks

2

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.